oncolytic herpes simplex virus (oHSV)-rQT3 for breast cancer treatment
This Project is based on the following Technology:
Leaders:
Managers:
Jason E. Barkeloo,
Li Guo
Tags:
cancer
biopharma
features
immunotherapy
amphiphilic
Recent Activity in this Project
-
Members
- Jason E. Barkeloo added on 04/28/2017
- Li Guo added on 04/28/2017
- Dr. Timothy Cripe added on 04/28/2017
-
Forum
- Breast cancer patient benefits from modified immunotherapy updated on 06/26/2018 by Jason E. Barkeloo
- Dr. Tim Cripe Ted Talk updated on 12/15/2017 by Jason E. Barkeloo
